Billionaire CEO Elon Musk said Wednesday his company Neuralink is ready to test its first cybernetic implant on a human patient.
In a blog post, Neuralink announced that recruitment is open for the first-in-human clinical trial of its wireless brain-computer interface (BCI). The Precise Robotically Implanted Brain-Computer Interface (PRIME) study will evaluate the safety of Neuralink’s implant (N1) and surgical robot (R1) and assess whether the device can help paralyzed people control external devices with their
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased